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OBJECTIVE: Heartburn and regurgitation are the most common gastroesophageal reflux symptoms, and
dysphagia could be a possible symptom. This investigation aimed to evaluate the prevalence of non-obstructive
dysphagia in patients with heartburn and regurgitation.
METHODS: A total of 147 patients (age, 20-70 years; women, 72%) complaining of heartburn and regurgitation,
without esophageal stricture, previous esophageal surgery, or other diseases, were evaluated. Twenty-seven
patients had esophagitis. The Eating Assessment Tool (EAT-10) was employed to screen for dysphagia; EAT-10 is
composed of 10 items, and the patients rate each item from 0 to 4 (0, no problems; 4, most severe symptom).
Results of the 147 patients were compared with those of 417 healthy volunteers (women, 62%; control group)
aged 20-68 years.
RESULTS: In the control group, only two (0.5%) had an EAT-10 score X5, which was chosen as the threshold to
define dysphagia. EAT-10 scores X5 were found in 71 (48.3%) patients and in 55% of the patients with
esophagitis and 47% of the patients without esophagitis. This finding indicates a relatively higher prevalence of
perceived dysphagia in patients with heartburn and regurgitation and in patients with esophagitis. We also
found a positive correlation between EAT-10 scores and the severity of gastroesophageal reflux symptoms based
on the Velanovich scale.
CONCLUSION: In patients with heartburn and regurgitation symptoms, the prevalence of dysphagia was at least
48%, and has a positive correlation with the overall symptoms of gastroesophageal reflux.
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’ INTRODUCTION
Gastroesophageal reflux disease (GERD) is prevalent
worldwide (1,2), and its incidence among young individuals
has been increasing (1). Although the most frequent symp-
toms are heartburn and regurgitation, other symptoms, such
as dysphagia, odynophagia, globus sensation, chest pain,
belching, chronic cough, laryngitis, hoarseness, and asthma,
may be present (3,4).
Dysphagia means difficulty in swallowing that may occur
in the oral, pharyngeal, or esophageal phases of swallowing
(5). Non-obstructive GERD is the most common identifiable
cause of esophageal dysphagia (6,7) and the major cause in
younger individuals. A previous study reported that non-
obstructive GERD was observed in approximately 24% of the
patients who sought treatment for dysphagia (6). Intermit-
tent dysphagia is independently associated with GERD (8),
and 31.6% and 18% of patients with GERD have fre-
quent and infrequent dysphagia, respectively (7). Moreover,
37-46.8% of patients with esophagitis reported dysphagia in
previous studies (9,10).
Symptom descriptions based on self-reports with dichot-
omized answers, i.e., yes or no, are not always precise (11)
and may be influenced by culture, beliefs, and ethnicity (12).
Thus, we used the validated instrument Eating Assess-
ment Tool (EAT–10), which evaluates dysphagia based on
an individual’s perception, to determine the prevalence
of dysphagia in patients with heartburn and regurgitation
in Brazil.
EAT-10 is a quick, easy-to-complete, non-invasive, inex-
pensive, and self-administered screening tool, which is based
on patient’s self-perception, to detect possible swallowing
impairment before performing a more specific examination
(13). This instrument has good internal consistency and test-
retest reproducibility and validity (13,14), with a sensitivity
of 0.85 and specificity of 0.82 to detect dysphagia (15);
moreover, it has the ability to predict aspiration (16-20). EAT-
10 is recommended as the first-line screening tool for at-risk
patients (15), has been validated in different languages,
and is currently used for dysphagia evaluation in differentDOI: 10.6061/clinics/2020/e1556
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populations (14,21-30). In addition, while this tool could be
used for both oropharyngeal and esophageal dysphagia, it is
most frequently used to detect the former (13). Each of the
10 questions can be rated from 0 to 4 (0, no problem; 4, severe
swallowing problem). Previous investigations found that
EAT-10 scores X3 is indicative of dysphagia (13,14,23,26),
and this cut-off value has a sensitivity of 0.76 and specificity
of 0.75 (31).
This study hypothesized that dysphagia is highly prevalent
in patients with heartburn and regurgitation and is associated
with the overall gastroesophageal reflux symptoms.
’ MATERIALS AND METHODS
In this study, EAT-10 was administered to 147 patients (106
[72%] women, 41 [28%] men) aged 20-68 years (mean 43.2
[13.2] years) who had heartburn and regurgitation (Table 1).
The patients completed the instrument just before endo-
scopic examination in a public tertiary hospital. They also
responded to the questionnaire on reflux symptoms pro-
posed by Velanovich et al. (32), which was translated to
Portuguese (33). Each of the 10 items in the questionnaire
could be rated from a 0 to 5 (0, no symptom; 5, incapacita-
ting symptom), with a possible total rating ranging from
0 to 50. None of the patients had esophageal stricture, history
of previous surgery of the upper digestive tract, or other
diseases, and they did not receive proton pump inhibitors
regularly.
Endoscopic examination revealed esophagitis in 25 patients
(11 Los Angeles classification (LA) grade A (34), 11 LA grade
B, two LA grade C, and one LA grade D), and two patients
had Barrett’s esophagus. No endoscopic abnormality was
found in the remaining 120 patients; moreover, none of
the patients had pharyngeal or esophageal strictures, cancer,
or eosinophilic esophagitis based on endoscopic findings.
Twenty-four-hour intraesophageal pH monitoring was per-
formed in 38 patients, with a pH probe placed 5 cm above the
lower esophageal sphincter after manometry. Excessive reflux
was considered when the acid exposure time (intraesophageal
pH o4) was greater than 6% of the monitoring time (35).
EAT-10 was also administered to 417 healthy individuals
(control group). These individuals had no disease, symp-
toms, or previous surgery of the upper digestive tract and
were not treated for any disease. This group was composed
of 257 (62%) women and 160 (38%) men aged 20 to 70 years
(mean 37.9 [14.3] years).
This study was approved by the Human Research Com-
mittee of the university hospital (IRB numbers 9635/2013
and 12220/2016). Written informed consent was obtained
from each participant, and anonymity of all participants was
guaranteed. The EAT-10 questionnaire was translated from
the original version to Brazilian Portuguese and validated
(21) (Table 2).
Statistical analysis was performed by non-parametric tests,
the Mann-Whitney test, Kruskal-Wallis test with pos-test of
Dunn, and Spearman test of correlation. The program used
was SAS 9.2 (SAS Inst., Cary NC, 2011). The results are
shown in mean, standard deviation, median, correlation
coefficient (rho), and percentage. A p value p0.05 was con-
sidered significant.
’ RESULTS
Figure 1 shows the EAT-10 scores in the control and study
groups. The total score ranged from 0 to 8 (mean 0.59,
median 0) in the control group and from 0 to 37 (mean 9.2,
median 4) in the study group (Table 1). If we consider EAT-
10 scores X3 as the threshold to define dysphagia, 29 con-
trols (6.9%) and 95 patients (64.6%) had dysphagia. Almost
all controls (99.3%) had EAT-10 scoresp4, which we used as
the threshold to define dysphagia in our study. Using this
threshold, the number of patients with dysphagia was
71(48.3%). Mean EAT-10 score in patients with dysphagia
(EAT-10 X5) was 17.5, and the median was 18 (range 5-37).
Moreover, mean EAT-10 score was 10.0 (9.9) in patients
with esophagitis and 9.1(10.2) in patients without esophagitis
(p40.05). EAT-10 score X5 was noted in 56% of the patients
with esophagitis and 47% of the patients without esophagitis
(p40.05). A positive correlation between EAT-10 scores
and Velanovich scores was found (po0.01; Table 3). Mean
Velanovich score was 30.3 (10.2), with a median of 31.
In addition, 20% of the patients who performed the mano-
metric examination had a diagnosis of ineffective esophageal
motility, with no association with EAT-10 scores (p40.05),
which suggested that a higher EAT-10 score may be observed
in patients with or without ineffective esophageal motility.
’ DISCUSSION
Based on the threshold of EAT-10 score X3, 64.6% of the
patients with heartburn and regurgitation had dysphagia,
and using the threshold EAT-10 score of X5, we found that
48.3% of the patients have dysphagia. These findings
indicated a high frequency of dysphagia among the patients
evaluated in Brazil.
In the patients included in this study, several conditions
may have been associated with heartburn and regurgitation,
including erosive GERD, non-erosive GERD, reflux hyper-
sensitivity, and functional heartburn (36). Although heart-
burn and regurgitation are the most frequent symptoms of
GERD, the sensitivity and specificity of these symptoms for
the identification of GERD are insufficient (sensitivity, 65%;
specificity, 75%) (2,4).
The presence of dysphagia in patients with heartburn and
regurgitation may be explained by the following:
A. Upper esophageal sphincter (UES) dysfunction.
Gastroesophageal reflux could influence UES function.
Patients with GERD have longer UES opening during deg-
lutition, which means a longer time for the bolus to pass
through the sphincter (37,38). Other UES changes have
been described, such as short and hypotonic sphincter (39)
Table 1 - Characteristics of the groups evaluated by the Eating
Assessment Tool (EAT-10).
Control group Study group
Number (n) 417 147
Women (%) 61.6 72.1
Age (years) 37.9 (14.3) 43.2 (13.2)
Height (m) 1.67 (0.09) 1.63 (0.09)
Weight (kg) 80.3 (26.7) 76.5 (15.3)
BMI (kg/m2) 28.8 (9.2) 28.8 (5.6)
Velanovich score _ 30.3 (10.2)
EAT-10 score 0.59 (1.2) 9.2 (10.1)*
BMI, body mass index
Data are expressed as mean (SD).
*po0.01 vs. controls
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and increased UES pressure associated with transient
lower esophageal sphincter relaxation (40). Reflux events
cause an intraesophageal pressure increase, which evokes
UES contractile response (41). Chronic acid exposure in the
esophageal body could cause hypertonicity of the UES and
thus difficulty in opening (42). The UES opening diameter
during swallowing was smaller in patients with than in
those without hiatal hernia (43). Slower passage of the
bolus through the UES has been associated with dyspha-
gia in patients with esophagitis (38), and a slower bolus
transit through the pharynx has also been reported in the
disease (37,38). A recent investigation found that patients
with reflux-associated dysphagia have delayed airway
closure relative to the arrival of the bolus at the UES,
suggesting a delay in airway protection when the bolus is
already in the pharynx (44).
Table 2 - Eating Assessment Tool (EAT-10) in Brazilian Portuguese.
O quanto as seguintes situac¸o˜es sa˜o problema´ticas para o senhor (a)
(To what extent are the following scenarios problematic for you)
0 = Sem problema
(No problem)
4 = Grave problema
(Severe problem)
1. Meu problema para engolir me faz perder peso
(My swallowing problem has caused me to lose weight)
0 1 2 3 4
2. Meu problema para engolir na˜o me deixa comer fora de casa
(My swallowing problem interferes with my ability to go out for meals)
0 1 2 3 4
3. Preciso fazer forc¸a para beber liquido
(Swallowing liquids takes extra effort)
0 1 2 3 4
4. Preciso fazer forc¸a para engolir comida (so´lidos)
(Swallowing solids takes extra effort)
0 1 2 3 4
5. Preciso fazer forc¸a para engolir reme´dios
(Swallowing pills takes extra effort)
0 1 2 3 4
6. Do´i para engolir
(Swallowing is painful)
0 1 2 3 4
7. Meu problema para engolir me tira o prazer de comer
(The pleasure of eating is affected by my swallowing)
0 1 2 3 4
8. Fico com comida presa/entalada na garganta
(When I swallow, food sticks in my throat)
0 1 2 3 4
9. Eu tusso quando como
(I cough when I eat)
0 1 2 3 4
10. Engolir me deixa estressado
(Swallowing is stressful)
0 1 2 3 4
Total EAT-10:
Figure 1 - Eating Assessment Tool (EAT -10) scores.
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B. Hypersensitivity
Some patients with heartburn may have abnormal esopha-
geal sensitivity to acid (reflux hypersensitivity), which is
characteristic of a functional esophageal disorder (45).
These patients have increased chemo- and mechano recep-
tor sensitivity to acid perfusion and balloon distention (45).
They manifest GERD symptoms during reflux even in the
absence of abnormal acid exposure or esophagitis (46,47).
In functional heartburn, the symptoms are not associated
with gastroesophageal reflux. Nevertheless, functional eso-
phageal disorders are associated with peripheral sensi-
tization, central sensitization, and viscera-visceral hyper-
algesia and cause a significant reduction in the quality of life
(46,48). Such hypersensitivity related to esophageal innerva-
tions (46) may increase patients’ perception of esophageal
bolus transit during swallows, and stress, anxiety, and hyper-
vigilance may have a role in the development of esophageal
hypersensitivity (49). In addition, calcitonin gene-related
positive nerves, which is a marker of nociceptive sensory
innervation, are more superficial in the proximal and
distal esophagus of patients with non-erosive reflux disease,
which may contribute to symptoms during swallows (50).
C. Esophageal dismotility
GERD may be the cause or the consequence of esophageal
dismotility (51,52). The frequency and intensity of esopha-
geal motility abnormalities increase with the severity of
reflux disease (52). Transient lower esophageal sphincter
relaxation followed by reflux, hypotensive lower esopha-
geal sphincter, ineffective esophageal peristalsis, and bolus
transit abnormalities are strongly implicated in GERD (53).
High-resolution esophageal manometry during solid
swallows demonstrated motility abnormality in patients
with a non-erosive disease, including ineffective swallows,
large breaks, and decreased distal contractile integral,
leading to a delay in acid clearance (53). Excessive esopha-
geal acid exposure with reduced esophageal peristaltic
contractions may be seen in a high proportion of patients
with dysphagia, even in those without heartburn and
regurgitation (49). These esophageal motility changes may
be the cause of non-obstructive dysphagia (54).
Results of the EAT-10 were associated with the severity
of gastroesophageal reflux symptoms, indicating that the
intensity of overall symptoms is related to dysphagia seve-
rity. Depressive disorders are frequently comorbid with
GERD (55) and may also be related to the intensity of the
symptoms, including the perception of dysphagia.
Previous investigations found that the odds ratio for
patients with heartburn to have frequent dysphagia is
5.9 and that for patients with acid regurgitation is 10.6 (7).
Among patients with dysphagia, 58% had heartburn, 67%
had regurgitation, and 72% had GERD, and an association
between intermittent dysphagia and GERD was observed
(odds ratio, 2.96) (8). Functional dysphagia is not the most
probable diagnosis because in the Rome IV criteria, GERD is
an exclusion criterion for functional dysphagia, which is the
least prevalent among functional esophageal disorders (48).
Although the definition of dysphagia and the methods of
evaluation may differ and thus yield different results, the
number of patients with symptomatic dysphagia is usually
high, suggesting that, after endoscopy, esophageal manome-
try with provocation testing is an essential examination to
determine the etiology of dysphagia.
This investigation has some limitations. The number of
patients with an erosive disease was small; however, it still
reflects the real-world situation, as only 30% of patients
with heartburn have an erosive disease (35). The 24-h pH
monitoring was not performed in all subjects because of
technical and cost limitations. The patients’ treatment for
GERD with proton pump inhibitors was not regular; they
were instructed to stop receiving the medications 1 week
before endoscopy and pH monitoring. Adequate treatment
for GERD decreases the frequency and severity of dysphagia
(9) and improves esophageal motility (49).
Therefore, heartburn and regurgitation are associated
with dysphagia, with somatization as a risk factor for non-
obstructive dysphagia (57). The complaint of dysphagia in
patients with no previous dysphagia may be a manifestation
of a complication, such as a benign or malignant esophageal
stricture. An anatomic cause of dysphagia, such as diverti-
cula or hiatal hernias, may not be seen on endoscopy, how-
ever, it is unlikely to occur in these patients because they
received medical attention and evaluations before the indi-
cation of endoscopy.
’ CONCLUSION
Using an EAT-10 score X5 as the threshold to define
dysphagia, we found that 48% of patients with heartburn and
regurgitation have dysphagia. This symptom has a positive
correlation with the overall symptoms of gastroesophageal
reflux, which suggested that the presence and intensity of
dysphagia are related to the symptoms due to GERD.
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Table 3 - Correlation of age, height, body mass index, and Velanovich score with EAT-10 scores (Spearman’s correlation coefficient
[rho]).
Control group (n=417) Study group (n=147)
rho 95% CI p rho 95% CI p
Age -0.23 -0.32 -0.13 o0.01 0.05 -0.11 0.21 0.52
Height -0.05 -0.14 0.05 0.34 -0.20 -0.35 -0.04 0.01
BMI -0.13 -0.22 -0.04 o0.01 -0.09 -0.25 0.07 0.26
Velanovich - - - - 0.59 0.45 0.69 o0.01
BMI, body mass index; CI, confidence interval.
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